Nagase & Co., Ltd.

8012.T
Specialty Chemicals
2026/11/06 12:54 Updated
Market Cap: $2.8B (¥437.2B)
Stock Price: $6.76 (¥1,072)
Exchange Rate: 1 USD = ¥158.48

Notice of Revision to Full-Year Consolidated Earnings Forecast

On November 6, 2026, Nagase & Co., Ltd. revised its full-year consolidated earnings forecast for the fiscal year ending March 2027. Net sales were revised upward by 85,080 million yen to 1,085,080 million yen, operating income was revised up by 13,500 million yen to 58,500 million yen, with upward revisions by segment as well. Foreign exchange assumptions were changed to 1 USD = 157.2 yen and 1 CNY = 23.4 yen.

Importance:
Page Updated: November 7, 2026
IR Disclosure Date: November 6, 2026

Key Figures

  • Net Sales: 1,085,080 million yen
  • Operating Income: 58,500 million yen
  • Net Income Attributable to Owners of Parent: 48,000 million yen

AI要約

Overview of Forecast Revision

Nagase & Co., Ltd. revised its full-year consolidated earnings forecast for the period from April 1, 2026 to March 31, 2027, relative to the forecast announced on May 7, 2026. Upward revisions were made to net sales and profits at each level across all segments, and the company now expects record-high profits on a full-year basis. The Materials, Electronics, and Life Science segments outperformed expectations; although Other & Corporate contains slight negative factors, overall profits are expected to increase. Foreign exchange assumptions were changed to 1 USD = 157.2 yen and 1 CNY = 23.4 yen.

Segment Impacts and Outlook

Materials were revised upward to net sales of 525,000 million yen and operating income of 24,500 million yen. Electronics were revised to net sales of 200,000 million yen and operating income of 21,000 million yen. Life Science was revised to net sales of 360,000 million yen and operating income of 9,500 million yen. Performance remained solid after the third quarter, but second-half profits are expected to be lower than first-half. Overall, the company forecasts a significant year-over-year increase in full-year profits.

Net Sales Trend

Operating Income Trend

Revenue by Segment

Operating Margin by Segment

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Nagase & Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →